BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Gaspà S, Dubreuil M, Guañabens N, Combalia A, Peris P, Monegal A, Parés A. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis. Eur J Clin Invest 2014;44:1206-14. [PMID: 25331234 DOI: 10.1111/eci.12355] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Braun C, Bacchetta J, Braillon P, Chapurlat R, Drai J, Reix P. Children and adolescents with cystic fibrosis display moderate bone microarchitecture abnormalities: data from high-resolution peripheral quantitative computed tomography. Osteoporos Int 2017;28:3179-88. [PMID: 28795206 DOI: 10.1007/s00198-017-4179-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Guañabens N, Parés A. Osteoporosis in chronic liver disease. Liver Int 2018;38:776-85. [PMID: 29479832 DOI: 10.1111/liv.13730] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
3 Zhang Y, Gao X, Liu T, Gao P, Li H, Liu N, Gao L, Wan G, Zhang Y, Duan X. Association between osteoporosis and hepatitis B cirrhosis: a case-control study. Afr Health Sci 2020;20:1610-6. [PMID: 34394221 DOI: 10.4314/ahs.v20i4.13] [Reference Citation Analysis]
4 Parés A, Guañabens N. Primary biliary cholangitis and bone disease. Best Pract Res Clin Gastroenterol 2018;34-35:63-70. [PMID: 30343712 DOI: 10.1016/j.bpg.2018.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
5 Hao W, Song J, Li G. Neuroprotective Effect of ω-3 Polyunsaturated Fatty Acids on Bilirubin Encephalopathy In Vitro and In Vivo. Med Sci Monit 2018;24:2631-8. [PMID: 29704452 DOI: 10.12659/MSM.907131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Yang YJ, Kim DJ. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. Int J Mol Sci 2021;22:2604. [PMID: 33807573 DOI: 10.3390/ijms22052604] [Reference Citation Analysis]
7 Li Y, Tong Z, Ling J. Effect of the three Enterococcus faecalis strains on apoptosis in MC 3T3 cells. Oral Dis 2018;25:309-18. [DOI: 10.1111/odi.12883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Carbone F, Oliveira PJ, Montecucco F. Protective role of necrostatin-1 in acute myocardial infarction. Eur J Clin Invest 2016;46:99-100. [DOI: 10.1111/eci.12568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Homchan K, Chaiwatanarat T, Udomsinprasert W, Chongsrisawat V, Poovorawan Y, Honsawek S. Low bone mineral density and the severity of cholestasis in biliary atresia. World J Hepatol 2017;9:746-51. [PMID: 28652893 DOI: 10.4254/wjh.v9.i16.746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Ruiz-Gaspà S, Guañabens N, Jurado S, Dubreuil M, Combalia A, Peris P, Monegal A, Parés A. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases. Gene 2020;725:144167. [PMID: 31639434 DOI: 10.1016/j.gene.2019.144167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Palmela I, Correia L, Silva RF, Sasaki H, Kim KS, Brites D, Brito MA. Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study. Front Neurosci 2015;9:80. [PMID: 25821432 DOI: 10.3389/fnins.2015.00080] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
12 Assis DN. Chronic Complications of Cholestasis: Evaluation and Management. Clin Liver Dis 2018;22:533-44. [PMID: 30259851 DOI: 10.1016/j.cld.2018.03.014] [Cited by in Crossref: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Hanafi NI, Mohamed AS, Sheikh Abdul Kadir SH, Othman MHD. Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart. Biomolecules 2018;8:E159. [PMID: 30486474 DOI: 10.3390/biom8040159] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
14 Wu P, Zhao J, Guo Y, Yu Y, Wu X, Xiao H. Ursodeoxycholic acid alleviates nonalcoholic fatty liver disease by inhibiting apoptosis and improving autophagy via activating AMPK. Biochem Biophys Res Commun 2020;529:834-8. [PMID: 32595039 DOI: 10.1016/j.bbrc.2020.05.128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Mahmoud YI. Testicular immunohistochemical and Ultrastructural changes associated with chronic cholestasis in rats: Effect of ursodeoxycholic acid. Life Sciences 2015;136:52-9. [DOI: 10.1016/j.lfs.2015.05.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]